D-0799-2020 Class II Terminated
FDA drug recall D-0799-2020 was initiated by Advanced Accelerator Applications USA, Inc. on Jan 10, 2020 and is designated Class II. Reason for recall: Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2). The recall status is terminated (terminated Jul 21, 2023). Affected quantity: 4295 Kits.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 29, 2020
- Initiation Date
- Jan 10, 2020
- Termination Date
- Jul 21, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4295 Kits
Product description
NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.
Reason for recall
Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
Distribution pattern
Nationwide in the US and Canada
Code information
Lot #: PG1919025, Exp. 07/11/2020; PG1919026, PG1919027, Exp. 07/16/2020.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0799-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026